A Randomized 2×2 Factorial Trial, Part 1: Single-Dose Rabbit Antithymocyte Globulin Induction May Improve Renal Transplantation Outcomes
Supplemental digital content is available in the text.
Main Authors: | Stevens, R. Brian, Foster, Kirk W., Miles, Clifford D., Lane, James T., Kalil, Andre C., Florescu, Diana F., Sandoz, John P., Rigley, Theodore H., Nielsen, Kathleen J., Skorupa, Jill Y., Kellogg, Anna M., Malik, Tamer, Wrenshall, Lucile E. |
---|---|
Format: | Online |
Language: | English |
Published: |
Lippincott Williams & Wilkins
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281164/ |
Similar Items
-
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology
by: Stevens, R. Brian, et al.
Published: (2015) -
Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
by: Roider, Tobias, et al.
Published: (2016) -
Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
by: Saidi, R. F., et al.
Published: (2011) -
Successful desensitization of a patient with aplastic anemia to antithymocyte globulin
by: Wolanin, Stephanie A., et al.
Published: (2015) -
A Double‐Blind, Double‐Dummy, Flexible‐Design Randomized Multicenter Trial: Early Safety of Single‐ Versus Divided‐Dose Rabbit Anti‐Thymocyte Globulin Induction in Renal Transplantation
by: Stevens, R. B., et al.
Published: (2016)